NHLRC3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.977900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.573800E-01
Normal-vs-Stage2
1.255630E-01
Normal-vs-Stage3
4.202100E-02
Normal-vs-Stage4
3.353800E-01
Stage1-vs-Stage2
5.797600E-01
Stage1-vs-Stage3
1.536450E-02
Stage1-vs-Stage4
8.127400E-01
Stage2-vs-Stage3
3.719800E-02
Stage2-vs-Stage4
8.038600E-01
Stage3-vs-Stage4
1.320180E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.918200E-02
Normal-vs-AfricanAmerican
4.112500E-02
Normal-vs-Asian
2.974200E-01
Caucasian-vs-AfricanAmerican
1.285360E-01
Caucasian-vs-Asian
5.584000E-01
AfricanAmerican-vs-Asian
1.008350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.223210E-01
Normal-vs-Female
9.216100E-02
Male-vs-Female
6.020600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.131000E-01
Normal-vs-Age(41-60Yrs)
1.338760E-01
Normal-vs-Age(61-80Yrs)
1.057610E-01
Normal-vs-Age(81-100Yrs)
7.816200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.392800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.902600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.070400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.872800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.215820E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.971800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.066360E-01
Normal-vs-Daily Drinker
2.122000E-02
Normal-vs-Weekly Drinker
3.881600E-01
Normal-vs-Occasional Drinker
1.068400E-01
Normal-vs-Social Drinker
3.267000E-01
Non Drinker-vs-Daily Drinker
2.573800E-01
Non Drinker-vs-Weekly Drinker
4.983800E-01
Non Drinker-vs-Occasional Drinker
6.638600E-01
Non Drinker-vs-Social Drinker
2.119200E-01
Daily Drinker-vs-Weekly Drinker
1.944170E-01
Daily Drinker-vs-Occasional Drinker
1.080760E-01
Daily Drinker-vs-Social Drinker
2.248400E-02
Weekly Drinker-vs-Occasional Drinker
7.553000E-01
Weekly Drinker-vs-Social Drinker
7.477200E-01
Occasional Drinker-vs-Social Drinker
3.705800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.932300E-02
Normal-vs-Grade 2
7.504200E-03
Normal-vs-Grade 3
3.257700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.752600E-01
Grade 1-vs-Grade 3
2.607600E-01
Grade 1-vs-Grade 4
7.932300E-02
Grade 2-vs-Grade 3
6.644000E-01
Grade 2-vs-Grade 4
7.504200E-03
Grade 3-vs-Grade 4
3.257700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.035650E-01
Normal-vs-NonDiabetic
7.710400E-02
Diabetic-vs-NonDiabetic
4.780600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.124980E-01
Normal-vs-NoPancreatitis
9.495500E-02
Pancreatitis-vs-NoPancreatitis
7.217200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.190980E-01
Normal-vs-N1
1.076420E-01
N0-vs-N1
8.465000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.011370E-01
Normal-vs-TP53-NonMutant
1.459180E-01
TP53-Mutant-vs-TP53-NonMutant
9.192600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
